Skip to content

Application of Laparoscopy in Gastrointestinal Injury

Study of Laparoscopy in Gastrointestinal Injury

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01994148
Enrollment
100
Registered
2013-11-25
Start date
2014-01-31
Completion date
2017-12-31
Last updated
2017-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Injury

Keywords

Trauma, Gastrointestinal injury, Laparoscopy

Brief summary

laparoscopy has been increasingly applied in patients with abdominal trauma , as an diagnostic and therapeutic modality. However, its clinical benefits are still under evaluation. The aim of this study is to prospectively assess the feasibility and safety of this technique in the management of traumatic gastrointestinal injury.

Detailed description

This prospective single arm study was undertaken in West China Hospital, Sichuan University, Chengdu, China. The institution is the largest medical center in southwest China, and also a national training center of laparoscopy. Surgeons participated in the study were well trained in gastrointestinal laparoscopy and hepatobiliary laparoscopy, and were experienced in management of abdominal trauma. The study was approved by the institutional review committees. The participants provided written informed consent. Patients age 18 years or older with abdominal trauma were considered eligible, regardless of the nature of trauma (blunt or penetrating), but hemodynamic stability was mandatory. Patients meet the following criteria is prepared for laparoscopic exploration: Evidence showed that wound penetrates the peritoneum in penetrating trauma or/and signs of peritoneal irritation or positive CT scan in those without penetration of peritoneum and patients with blunt injuries. We defined the CT scan positive by it shows peritoneal effusion, free intraperitoneal air, fat density increase, substantive organ rupture and intestinal wall swelling and other signs of abdominal trauma. Laparoscopic screening will be performed according to protocol. The study demands that all surgeons should complete the repair laparoscopically as much as possible when condition allow, and record reasons for conversion in detail when it is inevitable.

Interventions

PROCEDURELaparoscopy

In this study, laparoscopic intervention will be performed under carbon dioxide pneumoperitoneum (pressure, 10-12 mm Hg; flow volume, 8-10 L/min). A 12-mm trocar will be placed in the umbilicus with use of an open technique and to establish pneumoperitoneum.A 10-mm and a 5-mm trocar will be inserted in the right and left flanks,respectively.

Sponsors

Prof. Zongguang Zhou
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of gastrointestinal trauma * Blood loss \< 1000ml * Hemodynamically stable * Vital sign is stable * Willing to comply to the study procedure and complete the study.

Exclusion criteria

* Severe hemorrhage or intraperitoneal infections * Combined with other conditions which are contraindications to laparoscopy * Pregnant or lactating woman * Severe immunodeficiency * History of drug abuse

Design outcomes

Primary

MeasureTime frame
Mortality3 month after operation

Secondary

MeasureTime frameDescription
Number of patients with postoperative complicationsup to 3 monthsPostoperative complications include bowel obstruction, wound infection, postoperative hemorrhage,intestine fistula
Operative timeat the end of the operaion
Number of iatrogenic injury during the operationat the end of the operation
Length of hospital stay1 month
Number of patients transferred to open operationat the end of the operation
Blood loss during the operationat the end of the operation

Countries

China

Contacts

Primary ContactZongguang Zhou, MD., PhD.
zhou767@163.com18980601007
Backup ContactYuan Yin, MD.
yinyuan10@gmail.com15680600588

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026